Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › β-TrCP1, β-TrCP2 and RSK1 or RSK2 inhibitors and methods for sensitizing target cells to apoptosis

β-TrCP1, β-TrCP2 and RSK1 or RSK2 inhibitors and methods for sensitizing target cells to apoptosis

US Patent 8093043 · Granted Jan 10, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Automatic processing of electronic files to identify genetic variants2024
Automated configuration of flow cytometry machines2024
Determining drug effectiveness ranking for a patient using machine learning2023
Geranylgeranyltransferase I inhibitor for treatment of a PTEN defective cancer2023
Method of treating cancer with modulators of SCFSkp22016
USP47 inhibitors and methods to induce apoptosis2014
Methods to identify compounds useful for tumor sensitization to DNA damage2014
Modulating the Cdc14B-Cdh1-Plk1 axis and methods for sensitizing target cells to2013
Methods to identify compounds useful for tumor sensitization to DNA damage2013
USP47 inhibitors and methods to induce apoptosis2012
Modulating the CDC14B-CDH1-PLK1 axis and methods for sensitizing target cells to2012
Methods to identify compounds useful for the treatment of proliferative and diff2012